TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←
▶ 0:28 · Medical Imaging & Diagnostics · AI-automated COPD diagnosis replaces 1840s spirometry with 4-minute test
episode briefing
Scaling Europe

TidalSense diagnoses lung disease in under 4 minutes: Ameera Patel, CEO at TidalSense

2026-08-07 · 2 company · 8 thematic
sentiment
2 bull0 bear0 neu
speakers
ameera patel

Founder and CEO of Cambridge-based TidalSense, a respiratory technology company developing a handheld COPD diagnostic device using CO2 sensing and machine learning. Personally motivated by her own delayed asthma diagnosis and near-fatal attacks in her 20s.

now playing · Medical Imaging & Diagnostics
Medical Imaging & Diagnosticstailwindscore 8/10ameera patel
AI-automated COPD diagnosis replaces 1840s spirometry with 4-minute test
TidalSense uses miniaturized CO2 sensors and machine learning trained on specialist-labeled data to diagnose obstructive lung disease in under 4 minutes, eliminating the need for skilled op…
Medical Imaging & Diagnosticstailwindscore 8/10ameera patel
CO2 sensing + ML disrupts 180-year-old spirometry for COPD diagnosis
TidalSense replaces spirometry (unchanged since 1846) with a handheld CO2 sensor and ML interpretation that diagnoses COPD in under 4 minutes without skilled operators, enabling deployment…
Healthcare Systems & Policyheadwindscore 7/10ameera patel
Payment incentives, not technology, determine medtech adoption in US
Many effective medical devices fail commercially because US clinician reimbursement structures don't reward new diagnostic technologies, creating a structural barrier separate from clinical…
Medical Imaging & Diagnosticstailwindscore 7/10ameera patel
ML-encoded specialist diagnostics enable global scaling to underserved markets
By training ML models on specialist-labeled respiratory data, diagnostic expertise can be packaged into devices that work without local specialists, unlocking massive undiagnosed population…
AI in Healthcaretailwindscore 7/10ameera patel
ML models encode specialist diagnostic knowledge for global scale
By training ML models on specialist-labeled respiratory data, TidalSense automates interpretation, removing the need for local specialist expertise — a key barrier in countries lacking trai…
Healthcare Systems & Policytailwindscore 7/10ameera patel
Regulatory dual-track (FDA + EU MDR) creates global moat for medtech expansion
Securing both FDA and EU MDR Class 2A certification unlocks acceptance in most global markets, with US entry as the key value inflection for the next funding round and China's 100M COPD pat…
Healthcare Systems & Policytailwindscore 7/10ameera patel
Regulatory dual-track (EU MDR + FDA) unlocks global medical device markets
CEO highlights that securing both EU Class 2A and FDA clearance creates a regulatory passport accepted by most global markets, making US entry the critical milestone for worldwide scale — a…
Healthcare Systems & Policytailwindscore 6/10ameera patel
Regulatory dual-track (EU MDR + FDA) serves as global medtech passport
Achieving both EU Class 2A and FDA clearance allows medical device companies to access most global markets since many countries accept either certification, creating a clear regulatory path…